Login
Navigate Fool.com
Will PPHM beat
the market?
Community Rating: 1 Star: Ominous

1.54 0.03 (1.99%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.56
Previous Close $1.51
Daily Range $1.51 - $1.59
52-Week Range $0.42 - $5.50
Market Cap $211.2M
P/E Ratio -5.21
Dividend (Yield) $0.00 (0.0%)
Volume 1,339,125
Average Daily Volume 1,795,278
Current FY EPS -$0.23

How do you think PPHM
will perform against the market?

Top PPHM Bull/Bear Pitches

 

azurlo (0)
Submitted February 10, 2011

Strong late stage pipeline

0 Replies Reply Report this Post
 

AjarnMichael (< 20)
Submitted May 10, 2010

F

1 Replies Reply Report this Post

News & Commentary Rss Feed

Is Peregrine Preparing to Soar Again?

The company completes enrollment for a bavituximab breast cancer trial.

3 Stocks That Blew the Market Away

These three companies posted better than expected results on the bottom line.

A Fool Looks Back

Let's check out some of the stories that took place this past week.

February's Biggest Biotech Loser Bounces Back

Peregrine's roller coaster ride is as exciting for investors as it is nauseating.

5 Reasons Not to Worry This Week

These five companies are posting year-over-year improvements on the bottom line.

Peregrine Pharmaceuticals Earnings: An Early Look

Let's look forward to this company's next earnings report.

These 3 Stocks Fell Like a House of Cards

These stocks just rolled over. Can they come back?

Peregrine Investors: Once Bitten, Twice Shy

Investors aren't too excited about this secondary data analysis

2 of These 3 Stocks Look Like Damaged Goods

These stocks just rolled over. Can they come back?

Peregrine's Epic Failure (Maybe)

Peregrine Pharmaceuticals releases phase 2 data on bavituximab in pancreatic cancer without any p-values.

See More PPHM News...

Sector

Healthcare

Industry

Drugs

Peregrine Pharmaceuticals (PPHM) Description

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. Website: http://www.peregrineinc.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks